These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20970118)

  • 21. Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1H-magnetic resonance spectroscopy study.
    Gasparovic C; Yeo R; Mannell M; Ling J; Elgie R; Phillips J; Doezema D; Mayer AR
    J Neurotrauma; 2009 Oct; 26(10):1635-43. PubMed ID: 19355814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease.
    Hattori N; Abe K; Sakoda S; Sawada T
    Neuroreport; 2002 Jan; 13(1):183-6. PubMed ID: 11924885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Neurosci Lett; 2015 Oct; 606():7-12. PubMed ID: 26306650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.
    Fayed N; Garcia-Campayo J; Magallón R; Andrés-Bergareche H; Luciano JV; Andres E; Beltrán J
    Arthritis Res Ther; 2010; 12(4):R134. PubMed ID: 20609227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
    Kirov II; Tal A; Babb JS; Herbert J; Gonen O
    Neurology; 2013 Jan; 80(1):39-46. PubMed ID: 23175732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
    Tisell A; Leinhard OD; Warntjes JB; Aalto A; Smedby Ö; Landtblom AM; Lundberg P
    PLoS One; 2013; 8(4):e61817. PubMed ID: 23613944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology.
    Yadav SK; Gupta RK; Saraswat VA; Rangan M; Thomas MA; Rutella S; Danese S; Wang E; Marincola FM; Haris M
    J Transl Med; 2015 Oct; 13():322. PubMed ID: 26444271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
    Simister RJ; McLean MA; Barker GJ; Duncan JS
    Neurology; 2003 Oct; 61(7):897-902. PubMed ID: 14557556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study.
    Caprihan A; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C; Bustillo JR
    Neuropsychopharmacology; 2015 Aug; 40(9):2248-57. PubMed ID: 25786581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.
    Stone JM; Day F; Tsagaraki H; Valli I; McLean MA; Lythgoe DJ; O'Gorman RL; Barker GJ; McGuire PK;
    Biol Psychiatry; 2009 Sep; 66(6):533-9. PubMed ID: 19559402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.
    Fayed N; Andrés E; Viguera L; Modrego PJ; Garcia-Campayo J
    Acad Radiol; 2014 Sep; 21(9):1211-7. PubMed ID: 24981958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.
    Kraguljac NV; White DM; Reid MA; Lahti AC
    JAMA Psychiatry; 2013 Dec; 70(12):1294-302. PubMed ID: 24108440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
    He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
    Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.
    Reid MA; Kraguljac NV; Avsar KB; White DM; den Hollander JA; Lahti AC
    Schizophr Res; 2013 Jul; 147(2-3):348-54. PubMed ID: 23706412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
    Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
    Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia.
    Seese RR; O'Neill J; Hudkins M; Siddarth P; Levitt J; Tseng B; Wu KN; Caplan R
    Schizophr Res; 2011 Dec; 133(1-3):82-90. PubMed ID: 21872444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study.
    Keshavan MS; Dick RM; Diwadkar VA; Montrose DM; Prasad KM; Stanley JA
    Schizophr Res; 2009 Nov; 115(1):88-93. PubMed ID: 19748228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis.
    Wang AM; Pradhan S; Coughlin JM; Trivedi A; DuBois SL; Crawford JL; Sedlak TW; Nucifora FC; Nestadt G; Nucifora LG; Schretlen DJ; Sawa A; Barker PB
    JAMA Psychiatry; 2019 Mar; 76(3):314-323. PubMed ID: 30624573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.
    Kegeles LS; Shungu DC; Anjilvel S; Chan S; Ellis SP; Xanthopoulos E; Malaspina D; Gorman JM; Mann JJ; Laruelle M; Kaufmann CA
    Psychiatry Res; 2000 May; 98(3):163-75. PubMed ID: 10821999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.